Skip to main content

Closed

FHTX: Foghorn Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

34thpctl

Volume

0.64×avg

Market Cap

265.97MUSD

P/E Ratio

-3.9TTM

Div Yield

-ann

Foghorn Therapeutics Inc.

FHTXNASDAQ Global Market·USD·Closed

Foghorn Therapeutics Inc.

FHTXNASDAQ·USD·Closed

$4.53

−4.43%

$4.53

−$0.21 (4.43%)

52W Range

34thpctl

Volume

0.64×avg

Mkt Cap

265.97MUSD

P/E

-3.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings